LeMaitre Vascular, Inc. LMAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 67.97M | 70.38M | 66.55M | 64.45M | 61.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 67.97M | 70.38M | 66.55M | 64.45M | 61.05M |
| Cost of Revenue | 21.97M | 19.62M | 18.16M | 18.26M | 15.09M |
| Gross Profit | 46.01M | 50.76M | 48.40M | 46.19M | 45.96M |
| SG&A Expenses | 26.99M | 25.52M | 26.56M | 23.83M | 22.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.68M | 49.98M | 48.78M | 45.62M | 40.73M |
| Operating Income | 14.30M | 20.40M | 17.78M | 18.83M | 20.31M |
| Income Before Tax | 19.67M | 22.19M | 19.67M | 20.30M | 22.57M |
| Income Tax Expenses | 4.65M | 5.14M | 3.99M | 4.72M | 5.21M |
| Earnings from Continuing Operations | 15.02M | 17.05M | 15.68M | 15.58M | 17.36M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.02M | 17.05M | 15.68M | 15.58M | 17.36M |
| EBIT | 14.30M | 20.40M | 17.78M | 18.83M | 20.31M |
| EBITDA | 17.18M | 23.06M | 20.40M | 21.44M | 22.93M |
| EPS Basic | 0.66 | 0.75 | 0.69 | 0.69 | 0.77 |
| Normalized Basic EPS | 0.44 | 0.61 | 0.54 | 0.57 | 0.62 |
| EPS Diluted | 0.65 | 0.74 | 0.68 | 0.68 | 0.75 |
| Normalized Diluted EPS | 0.44 | 0.57 | 0.53 | 0.57 | 0.58 |
| Average Basic Shares Outstanding | 22.87M | 22.86M | 22.80M | 22.71M | 22.66M |
| Average Diluted Shares Outstanding | 23.07M | 24.53M | 23.03M | 22.97M | 24.39M |
| Dividend Per Share | 0.25 | 0.25 | 0.25 | 0.20 | 0.20 |
| Payout Ratio | 38.05% | 33.52% | 36.42% | 29.12% | 26.12% |